Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Biofilm Correlation and Validation

NCT: NCT05196880 · COMPLETED

NCT IDNCT05196880
StatusCOMPLETED
Start Date2022-02-15
Completion2023-11-08
SponsorMolecuLight Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, single-blind, controlled trial. There are two arms and 20 patients with acute or chronic wounds with clinical suspicion of biofilm (CSB+/CSB-) are allocated in each arm. The primary objective is to evaluate the diagnostic accuracy of MolecuLight fluorescence in identifying biofilm as validated by gold standard SEM imaging.

Frequently Asked Questions

What is Biofilm Correlation and Validation?

Biofilm Correlation and Validation is a clinical trial registered under NCT05196880. Current status: COMPLETED.

What is the status of NCT05196880?

The current status of NCT05196880 (Biofilm Correlation and Validation) is: COMPLETED.

When did Biofilm Correlation and Validation start?

Biofilm Correlation and Validation started on 2022-02-15.

Related Devices

K191371MolecuLight i:XMolecuLight, Inc. K210882MolecuLight I:XMolecuLight, Inc. K211901MolecuLightDXMolecuLight, Inc. K213840MolecuLight I:XMolecuLight, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑